Delcath Systems, Inc.
DCTH
Positions held
Your positionsDCTH isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $521.87M | Enterprise value | $428.43M | Trailing P/E | 1,504.00 | Forward P/E | 334.22 |
| PEG | 1.60 | Price / book | 4.30 | Beta | 0.60 | Dividend yield | 0.00% |
| Revenue growth | 20.6% | Earnings growth | 0.0% | Gross margin | 87.1% | Operating margin | 8.2% |
| Profit margin | 0.6% | ROE | 0.5% | ROA | -0.9% | Debt / equity | 0.02 |
| Current ratio | 9.83 | Free cash flow | $18.12M | Analyst recommendation | none | Mean target | $24.00 |
| 52w high | $17.42 | 52w low | $8.12 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $29.1M | $25.0M | $20.7M | $20.6M | $24.2M | — |
| Op margin | 8.2% | -6.5% | -10.5% | -1.9% | 10.7% | — |
| Net income | $2.7M | -$1.1M | -$1.9M | $0.8M | $2.7M | — |
| Gross margin | 89.8% | 85.1% | 85.5% | 87.2% | 86.3% | — |
| Gross profit | $26.1M | $21.3M | $17.7M | $17.9M | $20.8M | — |
| Operating income | $2.4M | -$1.6M | -$2.2M | -$0.4M | $2.6M | — |
- Revenue +17% vs prior quarter ($29M vs $25M).
- Gross margin 89.8% (was 85% prior quarter).
- Operating margin expanded to 8.2%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $85.2M | $37.2M | $2.1M | $2.7M | — |
| Op margin | 0.8% | -33.4% | -1849.0% | -1245.1% | — |
| Net income | $2.7M | -$26.4M | -$47.7M | -$36.5M | — |
| Gross margin | 86.2% | 83.4% | 69.2% | 74.8% | — |
| Gross profit | $73.4M | $31.0M | $1.4M | $2.0M | — |
| Operating income | $0.7M | -$12.4M | -$38.2M | -$33.9M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-01 · Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
2026-09-30 · 3 Emerging Biotech Stocks With Significant Upside Potential
2026-09-29 · Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?
2026-09-25 · Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?
2026-09-15 · Are Medical Stocks Lagging Delcath Systems (DCTH) This Year?
2026-09-11 · Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-11 · Delcath’s (DCTH) Liver Cancer Device Keeps Growing, But At A Cost
2026-09-08 · Zacks.com featured highlights include EuroDry, RCM, Assembly Biosciences, Delcath and National Energy Services
2026-09-08 · Keep Portfolio Volatility in Check With VLO, PBF, FET & DCTH
2026-09-04 · 5 Stocks With Recent Price Strength Buoyed by a Strong August
2026-08-31 · Delcath Systems to Participate in Upcoming Investor Conferences
2026-08-28 · What Makes Delcath Systems, Inc. (DCTH) a Strong Momentum Stock: Buy Now?
Price (daily)
Full chart · RSI · MACD · patterns